SEC Form 4 · accession 0001100682-26-000109
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 4:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | G | 153,361 | $0.00 | D | 126,596 | D | |
| Common StockF1 | Jun 5, 2026 | G | 153,361 | $0.00 | A | 155,611 | I | By Trust |
| Common StockF2 | Jun 5, 2026 | G | 20,000 | $0.00 | D | 106,596 | D | |
| Common StockF2 | Jun 5, 2026 | G | 20,000 | $0.00 | A | 20,000 | I | 2026 GRAT |
| Common StockF3 | Jun 5, 2026 | G | 10,000 | $0.00 | D | 0 | I | Held By Spouse |
| Common StockF3 | Jun 5, 2026 | G | 10,000 | $0.00 | A | 10,000 | I | By Trust Held By Spouse |
| Common Stock | holding | — | — | — | 10,780 | I | 2025 GRAT | |
| Common Stock | holding | — | — | — | 5,423 | I | 2024 GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares held by the reporting person to a revocable trust controlled by the reporting person.
- F2Reflects the exempt transfer pursuant to Rule 16a-13 of 20,000 shares held by the reporting person to a revocable trust controlled by the reporting person.
- F3Reflects the exempt transfer pursuant to Rule 16a-13 of 10,000 shares held by the reporting person's spouse to a revocable trust controlled by the reporting person's spouse.